Item 7.01. Regulation Disclosure.
A copy of a slide presentation (Presentation Materials") that Processa
Pharmaceuticals, Inc. ("Processa Pharmaceuticals") intends to publish to its
website, is attached to this Current Report on Form 8-K and Exhibit 99.1. The
Presentation Materials speak as of the date of this Current Report on Form 8-K.
While Processa Pharmaceuticals may elect to update the Presentation Materials in
the future or reflect events and circumstances occurring or existing after the
date of this Current Report on Form 8-K, Processa Pharmaceuticals specifically
disclaims any obligation to do so. The information contained in this Item 7.01
and Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by
reference in such a filing.
Item 9.01 Financial Statements and Exhibits
Exhibit No. Exhibit Description
99.1 Processa Pharmaceuticals Investor Presentation dated January 13,
2020
© Edgar Online, source Glimpses
